Risk of basal cell carcinoma in Swedish organ transplant recipients: A population-based study

British Journal of Dermatology

Volumn 174, Issue 1, 2016, Pages 95-103

  Krynitz, B ^a   Olsson, H ^a   Lundh Rozell, B ^b   Lindelof B ^a,c   Edgren, G ^a,c   Smedby, K E ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SKIN CARCINOMA; SUN; ADVERSE EFFECTS; AGE DISTRIBUTION; CARCINOMA, BASAL CELL; COMPARATIVE STUDY; INCIDENCE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSPECTIVE STUDY; SEX RATIO; SKIN NEOPLASMS; STATISTICS AND NUMERICAL DATA; SWEDEN;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, BASAL CELL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS; SWEDEN; TRANSPLANT RECIPIENTS;

EID: 84955588460     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14153     Document Type: Article

References (42)

1. Euvrard S, Kanitakis J, Claudy A,. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-91.
2. Wheless L, Jacks S, Mooneyham Potter KA, et al,. Skin cancer in organ transplant recipients: more than the immune system. J Am Acad Dermatol 2014; 71: 359-65.
3. Boukamp P,. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005; 26: 1657-67.
4. Fortina AB, Piaserico S, Caforio AL, et al,. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140: 1079-85.
5. Jensen AO, Svaerke C, Farkas D, et al,. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol 2010; 90: 474-9.
6. Krynitz B, Edgren G, Lindelöf B, et al,. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer 2013; 132: 1429-38.
7. National Board of Health and Welfare CfE. Cancer Incidence Sweden 2013. 2014. Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19613/2014-12-10.pdf (last accessed 30 November 2015).
8. Bordea C, Wojnarowska F, Millard PR, et al,. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77: 574-9.
9. Bouwes Bavinck JN, Hardie DR, Green A, et al,. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61: 715-21.
10. Hartevelt MM, Bavinck JN, Kootte AM, et al,. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506-9.
11. Ramsay HM, Fryer AA, Hawley CM, et al,. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 2002; 147: 950-6.
12. Harwood CA, Mesher D, McGregor JM, et al,. A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant 2013; 13: 119-29.
13. Moloney FJ, Comber H, O'Lorcain P, et al,. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154: 498-504.
14. National Board of Health and Welfare CfE. In-patient diseases in Sweden 1987-2006, vol. 2012. 2007. Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/9326/2007-42-17-20074218.pdf (last accessed 30 November 2015).
15. Ludvigsson JF, Andersson E, Ekbom A, et al,. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
16. National Board of Health and Welfare CfE. In English: Basal cell carcinoma in Sweden 2004-2008. 2009. Available at: http://www.socialstyrelsen.se/publikationer2009/2009-12-12 (last accessed 30 November 2015).
17. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A,. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-67.
18. National Board of Health and Welfare CfE. In English: The Swedish Cancer Register. 2011. Available at: http://www.socialstyrelsen.se/register/halsodataregister/cancerregistret/inenglish (last accessed 30 November 2015).
19. Barlow L, Westergren K, Holmberg L, Talbäck M,. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009; 48: 27-33.
20. Jernbeck J, Glaumann B, Glas JE,. [ Basal cell carcinoma. Clinical evaluation of the histological grading of aggressive types of cancer ]. Läkartidningen 1988; 85: 3467-70 (in Swedish).
21. Weedon D, LeBoit P, Burg G, Sarasin A, eds. Pathology and Genetics of Tumours of the Skin. Classification of Tumours. IARC, World Health Organization Classification of Tumours, 2005. Available to download at: http://www.iarc.fr/en/publications/pdfs-online/pat-gen/ (last accessed 30 November 2015).
22. Ulm K,. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990; 131: 373-5.
23. Birch-Johansen F, Jensen A, Mortensen L, et al,. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women. Int J Cancer 2010; 127: 2190-8.
24. Fuente MJ, Sabat M, Roca J, et al,. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149: 1221-6.
25. Naldi L, Fortina AB, Lovati S, et al,. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70: 1479-84.
26. Ramsay HM, Reece SM, Fryer AA, et al,. Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients. Transplantation 2007; 84: 437-9.
27. Brewer JD, Colegio OR, Phillips PK, et al,. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009; 145: 1391-6.
28. Ramsay HM, Fryer AA, Hawley CM, et al,. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49: 397-406.
29. Wisgerhof HC, Edelbroek JR, de Fijter JW, et al,. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors. Transplantation 2010; 89: 1231-8.
30. Armstrong BK, Kricker A,. The epidemiology of UV induced skin cancer. J Photochem Photobiol, B 2001; 63: 8-18.
31. Narayanan DL, Saladi RN, Fox JL,. Ultraviolet radiation and skin cancer. Int J Dermatol 2010; 49: 978-86.
32. Lindelöf B, Sigurgeirsson B, Wallberg P, et al,. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 1991; 25: 245-8.
33. Flohil SC, van der Leest RJ, Arends LR, et al,. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 2013; 49: 2365-75.
34. Knoll GA, Kokolo MB, Mallick R, et al,. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data. BMJ 2014; 349: g6679.
35. Kuschal C, Thoms KM, Schubert S, et al,. Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair. Exp Dermatol 2012; 21: 2-6.
36. Jayaraman SS, Rayhan DJ, Hazany S, et al,. Mutational landscape of basal cell carcinomas by whole-exome sequencing. J Invest Dermatol 2014; 134: 213-20.
37. Tilli CM, Van Steensel MA, Krekels GA, et al,. Molecular aetiology and pathogenesis of basal cell carcinoma. Br J Dermatol 2005; 152: 1108-24.
38. Harwood CA, Proby CM, McGregor JM, et al,. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54: 290-300.
39. Kanitakis J, Alhaj-Ibrahim L, Euvrard S, et al,. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 2003; 139: 1133-7.
40. Mertz KD, Proske D, Kettelhack N, et al,. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features. Int J Dermatol 2010; 49: 385-9.
41. Flohil SC, Proby CM, Forrest AD, et al,. Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions. Br J Dermatol 2012; 167 (Suppl. 2): 22-8.
42. Wallberg P, Skog E,. The incidence of basal cell carcinoma in an area of Stockholm County during the period 1971-1980. Acta Derm Venereol 1991; 71: 134-7.